In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Astellas Pharma has announced the promotion of James Robinson as president, Americas operations, for Astellas US, with responsibility for the company's operations in North and South America, effective April 1, 2016. 8 February 2016
Pharmaceutical
French drug major Sanofi on Friday named Muzammil Mansuri executive vice president, strategy & business development, effective February 22, 2016. 5 February 2016
Pharmaceutical
Stallergenes Greer has appointed Tibor Nemes as global head of technical operations. 2 February 2016
Pharmaceutical
Swiss pharma major Novartis, along with its financial results (see separate story) this morning, announced a major changes for its underperforming ophthalmic business Alcon, as well as some senior management appointments. 27 January 2016
Pharmaceutical
Germany’s Merck on Wednesday announced two appointments to head its businesses in North America and China in a bid to strengthen its position in the regions. 27 January 2016
Pharmaceutical
Valeant Pharmaceuticals’ chief executive Michael Pearson has said he is on the road to recovery but that he was uncertain about when he would return from medical leave. 26 January 2016
Pharmaceutical
Germany's Merck KGaA said it has appointed Jessie English as the vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. 21 January 2016
Pharmaceutical
Swedish Orphan Biovitrum today announced that Birgitte Volck, senior vice president of development and chief medical officer (CMO) of Sobi, will leave the company. 14 January 2016
Pharmaceutical
Switzerland-based Cardiorentis AG said it has raised 60 million Swiss Franc ($60 million) via private investors to advance its Phase III trials for Ularitide, a therapy for acute decompensated heart failure (ADHF), including upcoming regulatory submissions expected in the second half of 2016. 11 January 2016
Pharmaceutical
Israel-based Kitov Pharmaceuticals has appointed Gil Ben-Menachem as vice president business development. 8 January 2016
Pharmaceutical
Canadian drug maker Valeant Pharmaceuticals International said it has appointed Howard Schiller as interim chief executive. 7 January 2016
Pharmaceutical
Shares in Valeant Pharmaceuticals dropped over 10% on December 28 after the company said chief executive Michael Pearson is taking a medical leave with immediate effect. 4 January 2016
Pharmaceutical
British clinical stage drug development company Evgen Pharma has appointed a new chief medical officer, it has been announced. 4 January 2016
Pharmaceutical
US drugmaker MannKind Corp today announced the appointment of Duane DeSisto as its president and chief executive, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015. 24 December 2015
Pharmaceutical
KaloBios Pharmaceuticals Inc on Monday said that Martin Shkreli was terminated as chief executive officer of the and resigned from his position as a member of the board of directors. 21 December 2015
Pharmaceutical
Ariad Pharmaceuticals named Paris Panayiotopoulos president and chief executive officer, effective January 1, 2016. 21 December 2015
Pharmaceutical
Australian drug company Novogen has appointed Dr James Garner as its new chief executive, it has been announced. 10 December 2015
Pharmaceutical
Kesios Therapeutics, a portfolio company of Imperial Innovations Group which is developing novel therapeutics for the treatment of multiple myeloma and other cancers, has closed a £19.0 million ($28.6 million) Series A funding round from a syndicate of leading venture investors including Innovations, SV Life Sciences and Abingworth. 2 December 2015
Pharmaceutical
Belgian drug developer Ablynx on Monday named Robert Zeldin chief medical officer (CMO) effective December 1. 30 November 2015
Pharmaceutical
Presage Biosciences said it has in-licensed voruciclib, its first clinical stage drug program. 26 November 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze